Skip to main content

Table 1 Details of further diagnostic workup of men with an elevated PSA.

From: A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

 

Men not undergoing subsequent biopsy N = 259

Men who received a biopsy N = 370

Repeat PSA

72 (28%)

51 (14%)

   PSA

3.1 (2.4, 3.6)

4.6 (3.6, 7.2)

   PSA < 3 ng/ml (% of those with second PSA)

34 (47%)

5 (10%)

Digital rectal exam

114 (44%)

333 (90%)

   Abnormal findings (% of those with DRE)

16 (14%)

115 (35%)